OROGENIC ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.3% 2.3% 2.3% 2.3% 2.3%  
Bankruptcy risk  2.4% 1.3% 2.0% 1.6% 0.7%  
Credit score (0-100)  64 80 67 75 94  
Credit rating  BBB A A A AA  
Credit limit (kDKK)  0.0 120.5 0.7 27.4 1,554.4  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  5,003 4,405 4,957 7,244 9,502  
EBITDA  433 768 793 2,665 3,589  
EBIT  373 728 749 2,636 3,474  
Pre-tax profit (PTP)  321.8 744.3 727.9 2,570.6 3,525.8  
Net earnings  241.9 579.0 560.1 1,997.1 2,745.2  
Pre-tax profit without non-rec. items  322 744 728 2,571 3,526  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  48.6 124 79.6 49.9 390  
Shareholders equity total  4,579 5,158 5,718 7,715 10,461  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  12,603 13,824 12,925 19,051 17,981  

Net Debt  -1,485 -2,924 -529 -370 -5,611  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,003 4,405 4,957 7,244 9,502  
Gross profit growth  -29.8% -11.9% 12.5% 46.1% 31.2%  
Employees  8 6 6 6 7  
Employee growth %  -11.1% -25.0% 0.0% 0.0% 16.7%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  12,603 13,824 12,925 19,051 17,981  
Balance sheet change%  6.3% 9.7% -6.5% 47.4% -5.6%  
Added value  433.4 767.7 792.6 2,679.8 3,589.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -149 35 -88 -59 225  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  7.5% 16.5% 15.1% 36.4% 36.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  3.3% 6.3% 6.4% 17.1% 19.2%  
ROI %  6.2% 12.5% 12.3% 36.3% 38.9%  
ROE %  5.4% 11.9% 10.3% 29.7% 30.2%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  36.3% 37.3% 44.2% 40.5% 58.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -342.6% -380.8% -66.7% -13.9% -156.3%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  1.7 1.7 2.0 1.7 2.1  
Current Ratio  2.1 1.9 2.3 2.0 2.6  
Cash and cash equivalent  1,485.0 2,923.6 528.9 369.6 5,611.3  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  6,449.1 6,604.4 7,308.8 9,484.0 10,612.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  54 128 132 447 513  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  54 128 132 444 513  
EBIT / employee  47 121 125 439 496  
Net earnings / employee  30 96 93 333 392